Health Canada Approves New Alzheimer’s Drug: What is Donanemab? | Your Morning

A major medical milestone: Health Canada has officially approved Donanemab, a new treatment option for Canadians with early stage Alzheimer’s. With dementia impacting close to a million people across the country, what does this breakthrough mean for patient care? Dr. Saskia Sivananthan, neuroscientist and CEO of the Brain-Well Institute, joins us to explain the significance of this announcement. #Alzheimers #HealthCanada #Donanemab #DementiaCare #CdnHealth #MedicalBreakthrough #BrainHealth #canadanews Subscribe to Your Morning for the latest: http://bit.ly/2hX11GF Connect with Your Morning: https://www.ctv.ca/shows/your-morning Follow Your Morning on TikTok:   / yourmorningctv   Start YOUR MORNING with us. Hosts Anne-Marie Mediwake, Lindsey Deluce & Kelsey McEwen get you up to date on what Canadians will be talking about today, weekday mornings on CTV & CTV News Channel, 6am-9am ET (7am-10am AT, 730am-1030am NT)